

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | actin-myosin filament sliding (GO:0033275) | 9.15429151 |
| 2 | muscle filament sliding (GO:0030049) | 9.15429151 |
| 3 | sarcomere organization (GO:0045214) | 8.76482834 |
| 4 | regulation of skeletal muscle contraction (GO:0014819) | 8.07240965 |
| 5 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 7.76808742 |
| 6 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 7.64537282 |
| 7 | myofibril assembly (GO:0030239) | 7.55014610 |
| 8 | actin-mediated cell contraction (GO:0070252) | 7.51898947 |
| 9 | cardiac myofibril assembly (GO:0055003) | 7.20808909 |
| 10 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 6.70804196 |
| 11 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 6.64462692 |
| 12 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 6.55812689 |
| 13 | skeletal muscle adaptation (GO:0043501) | 6.47240018 |
| 14 | plasma membrane repair (GO:0001778) | 6.44984103 |
| 15 | skeletal muscle fiber development (GO:0048741) | 6.30949558 |
| 16 | skeletal muscle contraction (GO:0003009) | 6.27607096 |
| 17 | carnitine shuttle (GO:0006853) | 6.06294570 |
| 18 | cardiac muscle contraction (GO:0060048) | 6.01694538 |
| 19 | regulation of cell communication by electrical coupling (GO:0010649) | 5.95130599 |
| 20 | striated muscle contraction (GO:0006941) | 5.94423676 |
| 21 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 5.93623508 |
| 22 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 5.86897267 |
| 23 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 5.85769707 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 5.80730519 |
| 25 | tricarboxylic acid cycle (GO:0006099) | 5.72602116 |
| 26 | actomyosin structure organization (GO:0031032) | 5.67251648 |
| 27 | myotube cell development (GO:0014904) | 5.66102343 |
| 28 | actin filament-based movement (GO:0030048) | 5.63846922 |
| 29 | regulation of actin filament-based movement (GO:1903115) | 5.57687948 |
| 30 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 5.47395593 |
| 31 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 5.40274998 |
| 32 | cardiac muscle cell development (GO:0055013) | 5.34099082 |
| 33 | fatty acid transmembrane transport (GO:1902001) | 5.19270207 |
| 34 | striated muscle atrophy (GO:0014891) | 5.03485297 |
| 35 | cardiac cell development (GO:0055006) | 4.99529433 |
| 36 | creatine metabolic process (GO:0006600) | 4.97918690 |
| 37 | regulation of coenzyme metabolic process (GO:0051196) | 4.97859946 |
| 38 | regulation of cofactor metabolic process (GO:0051193) | 4.97859946 |
| 39 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 4.89021941 |
| 40 | response to inactivity (GO:0014854) | 4.85056683 |
| 41 | heart contraction (GO:0060047) | 4.84052782 |
| 42 | heart process (GO:0003015) | 4.84052782 |
| 43 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 4.76443018 |
| 44 | cardiac muscle tissue morphogenesis (GO:0055008) | 4.66658000 |
| 45 | cardiac muscle hypertrophy (GO:0003300) | 4.64638685 |
| 46 | adult heart development (GO:0007512) | 4.62729032 |
| 47 | striated muscle adaptation (GO:0014888) | 4.54444260 |
| 48 | regulation of striated muscle contraction (GO:0006942) | 4.54415873 |
| 49 | skeletal muscle tissue development (GO:0007519) | 4.54260286 |
| 50 | striated muscle hypertrophy (GO:0014897) | 4.52924683 |
| 51 | carnitine transmembrane transport (GO:1902603) | 4.45346951 |
| 52 | muscle contraction (GO:0006936) | 4.44722459 |
| 53 | glycogen catabolic process (GO:0005980) | 4.43190229 |
| 54 | regulation of sarcomere organization (GO:0060297) | 4.41431922 |
| 55 | ventricular cardiac muscle cell action potential (GO:0086005) | 4.37969935 |
| 56 | muscle tissue morphogenesis (GO:0060415) | 4.36045049 |
| 57 | muscle atrophy (GO:0014889) | 4.32265409 |
| 58 | glucan catabolic process (GO:0009251) | 4.13345348 |
| 59 | muscle cell cellular homeostasis (GO:0046716) | 4.12725292 |
| 60 | fructose metabolic process (GO:0006000) | 4.11524971 |
| 61 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 4.10933965 |
| 62 | muscle system process (GO:0003012) | 4.06990288 |
| 63 | carnitine transport (GO:0015879) | 4.05923813 |
| 64 | amino-acid betaine transport (GO:0015838) | 4.05923813 |
| 65 | regulation of sulfur metabolic process (GO:0042762) | 4.04389460 |
| 66 | regulation of membrane repolarization (GO:0060306) | 4.03589338 |
| 67 | muscle hypertrophy (GO:0014896) | 4.00029628 |
| 68 | heart trabecula formation (GO:0060347) | 3.96217516 |
| 69 | glycogen metabolic process (GO:0005977) | 3.95870280 |
| 70 | ventricular cardiac muscle tissue morphogenesis (GO:0055010) | 3.91361461 |
| 71 | gluconeogenesis (GO:0006094) | 3.90156636 |
| 72 | response to muscle activity (GO:0014850) | 3.89442582 |
| 73 | positive regulation of myotube differentiation (GO:0010831) | 3.88273479 |
| 74 | glucan metabolic process (GO:0044042) | 3.88114848 |
| 75 | cellular glucan metabolic process (GO:0006073) | 3.88114848 |
| 76 | cellular polysaccharide catabolic process (GO:0044247) | 3.85013343 |
| 77 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 3.84231593 |
| 78 | response to activity (GO:0014823) | 3.79974311 |
| 79 | muscle organ morphogenesis (GO:0048644) | 3.79516064 |
| 80 | 2-oxoglutarate metabolic process (GO:0006103) | 3.78089718 |
| 81 | muscle cell fate commitment (GO:0042693) | 3.77027858 |
| 82 | NADH metabolic process (GO:0006734) | 3.76552532 |
| 83 | muscle adaptation (GO:0043500) | 3.76249539 |
| 84 | regulation of calcium ion transmembrane transport (GO:1903169) | 3.72781001 |
| 85 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 3.72781001 |
| 86 | striated muscle cell development (GO:0055002) | 3.72693089 |
| 87 | muscle organ development (GO:0007517) | 3.71878482 |
| 88 | muscle structure development (GO:0061061) | 3.71858454 |
| 89 | negative regulation of calcium ion transmembrane transporter activity (GO:1901020) | 3.67001396 |
| 90 | negative regulation of calcium ion transmembrane transport (GO:1903170) | 3.67001396 |
| 91 | pyrimidine ribonucleoside catabolic process (GO:0046133) | 3.63308723 |
| 92 | polysaccharide catabolic process (GO:0000272) | 3.62435329 |
| 93 | muscle fiber development (GO:0048747) | 3.62213603 |
| 94 | positive regulation of cation channel activity (GO:2001259) | 3.59506061 |
| 95 | glucan biosynthetic process (GO:0009250) | 3.58544099 |
| 96 | glycogen biosynthetic process (GO:0005978) | 3.58544099 |
| 97 | cardiac muscle adaptation (GO:0014887) | 3.58018731 |
| 98 | cardiac muscle hypertrophy in response to stress (GO:0014898) | 3.58018731 |
| 99 | muscle hypertrophy in response to stress (GO:0003299) | 3.58018731 |
| 100 | hexose biosynthetic process (GO:0019319) | 3.48133680 |
| 101 | regulation of the force of heart contraction (GO:0002026) | 3.45660529 |
| 102 | mitochondrial electron transport, NADH to ubiquinone (GO:0006120) | 3.45355559 |
| 103 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.45277239 |
| 104 | regulation of sequestering of triglyceride (GO:0010889) | 3.43124595 |
| 105 | mitochondrial ATP synthesis coupled proton transport (GO:0042776) | 3.42698514 |
| 106 | myoblast fusion (GO:0007520) | 3.40652350 |
| 107 | skeletal muscle tissue regeneration (GO:0043403) | 3.39924162 |
| 108 | oxidative phosphorylation (GO:0006119) | 3.39271116 |
| 109 | respiratory electron transport chain (GO:0022904) | 3.38645523 |
| 110 | neuronal action potential propagation (GO:0019227) | 3.38531002 |
| 111 | positive regulation of mitochondrial calcium ion concentration (GO:0051561) | 3.38462256 |
| 112 | cell communication involved in cardiac conduction (GO:0086065) | 3.38421723 |
| 113 | relaxation of muscle (GO:0090075) | 3.34534269 |
| 114 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.33729307 |
| 115 | muscle cell development (GO:0055001) | 3.31717813 |
| 116 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.31099157 |
| 117 | cytidine metabolic process (GO:0046087) | 3.30664607 |
| 118 | cytidine catabolic process (GO:0006216) | 3.30664607 |
| 119 | cytidine deamination (GO:0009972) | 3.30664607 |
| 120 | regulation of ATP catabolic process (GO:1903289) | 3.29706913 |
| 121 | regulation of ATPase activity (GO:0043462) | 3.29706913 |
| 122 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 3.28642555 |
| 123 | cardiac muscle cell action potential (GO:0086001) | 3.28569797 |
| 124 | IMP metabolic process (GO:0046040) | 3.28377486 |
| 125 | electron transport chain (GO:0022900) | 3.27544045 |
| 126 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 3.24935202 |
| 127 | regulation of muscle system process (GO:0090257) | 3.23520784 |
| 128 | oxaloacetate metabolic process (GO:0006107) | 3.22237697 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 5.72034136 |
| 2 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 4.59074404 |
| 3 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 3.97104757 |
| 4 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 3.88672659 |
| 5 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 3.87906408 |
| 6 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 3.70341364 |
| 7 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 3.70341364 |
| 8 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 3.36700866 |
| 9 | ZNF263_19887448_ChIP-Seq_K562_Human | 2.90843987 |
| 10 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 2.69980347 |
| 11 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 2.53163939 |
| 12 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.41266724 |
| 13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.35757633 |
| 14 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 2.24563191 |
| 15 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 2.23871637 |
| 16 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.20946311 |
| 17 | EZH2_22144423_ChIP-Seq_EOC_Human | 2.18671086 |
| 18 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 2.07115223 |
| 19 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.99923284 |
| 20 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.84517754 |
| 21 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.82206082 |
| 22 | ESR2_21235772_ChIP-Seq_MCF-7_Human | 1.74795083 |
| 23 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.70239552 |
| 24 | BCL3_23251550_ChIP-Seq_MUSCLE_Mouse | 1.63978768 |
| 25 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.63780310 |
| 26 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.53559125 |
| 27 | * TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.52241744 |
| 28 | ZNF652_21678463_ChIP-ChIP_ZR75-1_Human | 1.52020610 |
| 29 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.51379161 |
| 30 | CREB1_26743006_Chip-Seq_LNCaP-abl_Human | 1.47566690 |
| 31 | DROSHA_22980978_ChIP-Seq_HELA_Human | 1.44185344 |
| 32 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 1.38983882 |
| 33 | PPARA_22158963_ChIP-Seq_LIVER_Mouse | 1.37975938 |
| 34 | CTCF_27219007_Chip-Seq_Bcells_Human | 1.37535112 |
| 35 | RBPJ_22232070_ChIP-Seq_NCS_Mouse | 1.29314386 |
| 36 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.28362687 |
| 37 | KDM2B_26808549_Chip-Seq_SUP-B15_Human | 1.25402016 |
| 38 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 1.25291579 |
| 39 | * EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.24762381 |
| 40 | PBX_27287812_Chip-Seq_EMBYONIC-LIMB_Mouse | 1.24525266 |
| 41 | STAT3_19079543_ChIP-ChIP_MESCs_Mouse | 1.24050332 |
| 42 | NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 1.20658825 |
| 43 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.20176610 |
| 44 | ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.19634526 |
| 45 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.19565927 |
| 46 | KDM2B_26808549_Chip-Seq_DND41_Human | 1.18991821 |
| 47 | * PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.18409993 |
| 48 | TBP_23326641_ChIP-Seq_C3H10T1-2_Mouse | 1.16937243 |
| 49 | SOX9_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 1.13417940 |
| 50 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11793543 |
| 51 | MYC_27129775_Chip-Seq_CORNEA_Mouse | 1.10549422 |
| 52 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.08867958 |
| 53 | RXR_22158963_ChIP-Seq_LIVER_Mouse | 1.08585247 |
| 54 | NR0B1_18358816_ChIP-ChIP_MESCs_Mouse | 1.07168476 |
| 55 | CTCF_21964334_ChIP-Seq_BJAB-B_Human | 1.07135265 |
| 56 | FOXH1_21741376_ChIP-Seq_ESCs_Human | 1.04561512 |
| 57 | E4F1_26484288_ChIP-Seq_MOUSE_EMBRYONIC_FIBROBLAST_Mouse | 1.04483471 |
| 58 | TP63_22573176_ChIP-Seq_HFKS_Human | 1.03953666 |
| 59 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 1.03237259 |
| 60 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.01368640 |
| 61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.01301196 |
| 62 | SMC3_22415368_ChIP-Seq_MEFs_Mouse | 1.01114762 |
| 63 | STAT6_21828071_ChIP-Seq_BEAS2B_Human | 1.01058675 |
| 64 | LXR_22292898_ChIP-Seq_THP-1_Human | 1.01013196 |
| 65 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.00947184 |
| 66 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 0.97519017 |
| 67 | OCT4_20526341_ChIP-Seq_ESCs_Human | 0.97210969 |
| 68 | DNAJC2_21179169_ChIP-ChIP_NT2_Human | 0.96689447 |
| 69 | SPI1_20517297_ChIP-Seq_HL60_Human | 0.96350894 |
| 70 | RACK7_27058665_Chip-Seq_MCF-7_Human | 0.96321304 |
| 71 | GATA1_22025678_ChIP-Seq_K562_Human | 0.95419156 |
| 72 | GATA6_21074721_ChIP-Seq_CACO-2_Mouse | 0.95261895 |
| 73 | FOXP2_23625967_ChIP-Seq_PFSK-1_AND_SK-N-MC_Human | 0.94336101 |
| 74 | ZFP281_18757296_ChIP-ChIP_E14_Mouse | 0.93242787 |
| 75 | FOXA2_19822575_ChIP-Seq_HepG2_Human | 0.92716389 |
| 76 | IGF1R_20145208_ChIP-Seq_DFB_Human | 0.92481260 |
| 77 | RUNX1_27514584_Chip-Seq_MCF-7_Human | 0.91715866 |
| 78 | ATF3_27146783_Chip-Seq_COLON_Human | 0.89775128 |
| 79 | CREB1_26743006_Chip-Seq_LNCaP_Human | 0.89074965 |
| 80 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 0.88844770 |
| 81 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 0.88790055 |
| 82 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 0.88590510 |
| 83 | ISL1_27105846_Chip-Seq_CPCs_Mouse | 0.88307677 |
| 84 | SMC1_22415368_ChIP-Seq_MEFs_Mouse | 0.88121088 |
| 85 | SOX6_21985497_ChIP-Seq_MYOTUBES_Mouse | 0.87974993 |
| 86 | EGR1_20690147_ChIP-Seq_ERYTHROLEUKEMIA_Human | 0.87871196 |
| 87 | KLF6_26769127_Chip-Seq_PDAC-Cell_line_Human | 0.87184555 |
| 88 | P68_20966046_ChIP-Seq_HELA_Human | 0.86700774 |
| 89 | SOX9_24532713_ChIP-Seq_HFSC_Mouse | 0.86167996 |
| 90 | SRY_25088423_ChIP-ChIP_EMBRYONIC_GONADS_Mouse | 0.86101361 |
| 91 | GATA2_19941826_ChIP-Seq_K562_Human | 0.86002709 |
| 92 | TDRD3_21172665_ChIP-Seq_MCF-7_Human | 0.85640243 |
| 93 | SMAD3_22036565_ChIP-Seq_ESCs_Mouse | 0.84916026 |
| 94 | MTF2_20144788_ChIP-Seq_MESCs_Mouse | 0.84783154 |
| 95 | RAD21_21589869_ChIP-Seq_MESCs_Mouse | 0.84081737 |
| 96 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 0.83961559 |
| 97 | RARB_27405468_Chip-Seq_BRAIN_Mouse | 0.83706572 |
| 98 | PRDM14_21183938_ChIP-Seq_MESCs_Mouse | 0.82969256 |
| 99 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.82375304 |
| 100 | CTCF_27219007_Chip-Seq_ERYTHROID_Human | 0.81533949 |
| 101 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.81493056 |
| 102 | UBF1/2_26484160_Chip-Seq_HMEC-DERIVED_Human | 0.81443141 |
| 103 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.81424634 |
| 104 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.80596646 |
| 105 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.80394888 |
| 106 | ELK3_25401928_ChIP-Seq_HUVEC_Human | 0.80126868 |
| 107 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 0.80044494 |
| 108 | MYCN_27167114_Chip-Seq_NEUROBLASTOMA_Human | 0.79966310 |
| 109 | STAT3_1855785_ChIP-Seq_MESCs_Mouse | 0.79887865 |
| 110 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 0.79363125 |
| 111 | SMAD2/3_21741376_ChIP-Seq_ESCs_Human | 0.78927522 |
| 112 | GATA1_19941827_ChIP-Seq_MEL_Mouse | 0.78688233 |
| 113 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.78487536 |
| 114 | SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.78397710 |
| 115 | AR_21572438_ChIP-Seq_LNCaP_Human | 0.78349495 |
| 116 | ERA_27197147_Chip-Seq_ENDOMETRIOID-ADENOCARCINOMA_Human | 0.78127464 |
| 117 | * CJUN_26792858_Chip-Seq_BT549_Human | 0.77915147 |
| 118 | WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.77515002 |
| 119 | CTCF_21964334_Chip-Seq_Bcells_Human | 0.77476681 |
| 120 | SA1_27219007_Chip-Seq_Bcells_Human | 0.77416154 |
| 121 | EZH2_27294783_Chip-Seq_ESCs_Mouse | 0.77392563 |
| 122 | AUTS2_25519132_ChIP-Seq_293T-REX_Human | 0.77226480 |
| 123 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.77102737 |
| 124 | LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.76211484 |
| 125 | TP53_20018659_ChIP-ChIP_R1E_Mouse | 0.76123988 |
| 126 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 0.75934123 |
| 127 | DPY_21335234_ChIP-Seq_ESCs_Mouse | 0.75885395 |
| 128 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 0.74208955 |
| 129 | GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.73040405 |
| 130 | EGR1_19032775_ChIP-ChIP_M12_Human | 0.72271590 |
| 131 | TCF7_22412390_ChIP-Seq_EML_Mouse | 0.71999129 |
| 132 | GATA6_21074721_ChIP-Seq_CACO-2_Human | 0.70226638 |
| 133 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 0.70152082 |
| 134 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 0.70152082 |
| 135 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 0.69739660 |
| 136 | RNF2_18974828_ChIP-Seq_MESCs_Mouse | 0.69001555 |
| 137 | EZH2_18974828_ChIP-Seq_MESCs_Mouse | 0.69001555 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0003646_muscle_fatigue | 6.31490563 |
| 2 | MP0002837_dystrophic_cardiac_calcinosis | 6.15778976 |
| 3 | MP0000751_myopathy | 5.54565297 |
| 4 | MP0000749_muscle_degeneration | 4.93706705 |
| 5 | MP0004145_abnormal_muscle_electrophysio | 4.78524287 |
| 6 | MP0004084_abnormal_cardiac_muscle | 4.50730814 |
| 7 | MP0004036_abnormal_muscle_relaxation | 4.39402868 |
| 8 | MP0004215_abnormal_myocardial_fiber | 3.65837339 |
| 9 | MP0004087_abnormal_muscle_fiber | 3.37496221 |
| 10 | MP0002106_abnormal_muscle_physiology | 3.28160615 |
| 11 | MP0005330_cardiomyopathy | 3.26135504 |
| 12 | MP0004130_abnormal_muscle_cell | 3.17889057 |
| 13 | MP0000750_abnormal_muscle_regeneration | 3.03952102 |
| 14 | MP0002269_muscular_atrophy | 3.02565856 |
| 15 | MP0005620_abnormal_muscle_contractility | 2.96608127 |
| 16 | MP0000747_muscle_weakness | 2.94614609 |
| 17 | MP0000759_abnormal_skeletal_muscle | 2.76451716 |
| 18 | MP0005369_muscle_phenotype | 2.70254598 |
| 19 | MP0002972_abnormal_cardiac_muscle | 2.59911582 |
| 20 | MP0004233_abnormal_muscle_weight | 2.26719265 |
| 21 | MP0003137_abnormal_impulse_conducting | 2.25347934 |
| 22 | MP0010630_abnormal_cardiac_muscle | 2.18687669 |
| 23 | MP0004484_altered_response_of | 2.15484132 |
| 24 | MP0008775_abnormal_heart_ventricle | 2.13786408 |
| 25 | MP0001544_abnormal_cardiovascular_syste | 2.08688127 |
| 26 | MP0005385_cardiovascular_system_phenoty | 2.08688127 |
| 27 | MP0006036_abnormal_mitochondrial_physio | 1.91783073 |
| 28 | MP0003221_abnormal_cardiomyocyte_apopto | 1.82887208 |
| 29 | MP0006138_congestive_heart_failure | 1.78132698 |
| 30 | MP0002332_abnormal_exercise_endurance | 1.78126236 |
| 31 | MP0003828_pulmonary_edema | 1.61505163 |
| 32 | MP0004085_abnormal_heartbeat | 1.56461330 |
| 33 | MP0004510_myositis | 1.56320166 |
| 34 | MP0005666_abnormal_adipose_tissue | 1.55433111 |
| 35 | MP0004185_abnormal_adipocyte_glucose | 1.39828454 |
| 36 | MP0002108_abnormal_muscle_morphology | 1.35181119 |
| 37 | MP0005670_abnormal_white_adipose | 1.34570042 |
| 38 | MP0002127_abnormal_cardiovascular_syste | 1.33270907 |
| 39 | MP0000733_abnormal_muscle_development | 1.20458635 |
| 40 | MP0003950_abnormal_plasma_membrane | 1.16852030 |
| 41 | MP0005375_adipose_tissue_phenotype | 1.11873738 |
| 42 | MP0002234_abnormal_pharynx_morphology | 1.01535815 |
| 43 | MP0000343_altered_response_to | 1.01322794 |
| 44 | MP0006035_abnormal_mitochondrial_morpho | 0.99671790 |
| 45 | MP0001661_extended_life_span | 0.99073227 |
| 46 | MP0000266_abnormal_heart_morphology | 0.96054065 |
| 47 | MP0005266_abnormal_metabolism | 0.93434751 |
| 48 | MP0000013_abnormal_adipose_tissue | 0.88171114 |
| 49 | MP0003567_abnormal_fetal_cardiomyocyte | 0.87037540 |
| 50 | MP0003806_abnormal_nucleotide_metabolis | 0.85046145 |
| 51 | MP0002971_abnormal_brown_adipose | 0.84280425 |
| 52 | MP0005165_increased_susceptibility_to | 0.78019758 |
| 53 | MP0004043_abnormal_pH_regulation | 0.71370484 |
| 54 | MP0000230_abnormal_systemic_arterial | 0.69452238 |
| 55 | MP0003705_abnormal_hypodermis_morpholog | 0.68724263 |
| 56 | MP0000003_abnormal_adipose_tissue | 0.67503688 |
| 57 | MP0003279_aneurysm | 0.67409678 |
| 58 | MP0004147_increased_porphyrin_level | 0.62837128 |
| 59 | MP0002078_abnormal_glucose_homeostasis | 0.61419178 |
| 60 | MP0002128_abnormal_blood_circulation | 0.59833627 |
| 61 | MP0002909_abnormal_adrenal_gland | 0.59525070 |
| 62 | MP0005334_abnormal_fat_pad | 0.57385691 |
| 63 | MP0000372_irregular_coat_pigmentation | 0.56871769 |
| 64 | MP0008961_abnormal_basal_metabolism | 0.55436729 |
| 65 | MP0003879_abnormal_hair_cell | 0.53435828 |
| 66 | MP0010368_abnormal_lymphatic_system | 0.50654455 |
| 67 | MP0004134_abnormal_chest_morphology | 0.47534700 |
| 68 | MP0005319_abnormal_enzyme/_coenzyme | 0.47247798 |
| 69 | MP0003566_abnormal_cell_adhesion | 0.45575286 |
| 70 | MP0005623_abnormal_meninges_morphology | 0.45130510 |
| 71 | MP0009840_abnormal_foam_cell | 0.42978021 |
| 72 | MP0005187_abnormal_penis_morphology | 0.41368918 |
| 73 | MP0002638_abnormal_pupillary_reflex | 0.41191544 |
| 74 | MP0010030_abnormal_orbit_morphology | 0.39677525 |
| 75 | MP0001346_abnormal_lacrimal_gland | 0.38352708 |
| 76 | MP0000767_abnormal_smooth_muscle | 0.38206954 |
| 77 | MP0005167_abnormal_blood-brain_barrier | 0.38171718 |
| 78 | MP0005535_abnormal_body_temperature | 0.38119902 |
| 79 | MP0001879_abnormal_lymphatic_vessel | 0.38028116 |
| 80 | MP0003656_abnormal_erythrocyte_physiolo | 0.36717920 |
| 81 | MP0004270_analgesia | 0.35456199 |
| 82 | MP0005584_abnormal_enzyme/coenzyme_acti | 0.35101209 |
| 83 | MP0001299_abnormal_eye_distance/ | 0.34971935 |
| 84 | MP0003045_fibrosis | 0.34431448 |
| 85 | MP0003195_calcinosis | 0.34035636 |
| 86 | MP0005166_decreased_susceptibility_to | 0.33778513 |
| 87 | MP0005451_abnormal_body_composition | 0.33655519 |
| 88 | MP0005275_abnormal_skin_tensile | 0.32559335 |
| 89 | MP0002118_abnormal_lipid_homeostasis | 0.32013857 |
| 90 | MP0005083_abnormal_biliary_tract | 0.31162187 |
| 91 | MP0002925_abnormal_cardiovascular_devel | 0.30992917 |
| 92 | MP0009672_abnormal_birth_weight | 0.30876670 |
| 93 | MP0004142_abnormal_muscle_tone | 0.30782851 |
| 94 | MP0002114_abnormal_axial_skeleton | 0.30021466 |
| 95 | MP0003948_abnormal_gas_homeostasis | 0.29959584 |
| 96 | MP0005452_abnormal_adipose_tissue | 0.29442899 |
| 97 | MP0009780_abnormal_chondrocyte_physiolo | 0.28702153 |
| 98 | MP0005423_abnormal_somatic_nervous | 0.28335678 |
| 99 | MP0005332_abnormal_amino_acid | 0.28058764 |
| 100 | MP0009115_abnormal_fat_cell | 0.27511015 |
| 101 | MP0008438_abnormal_cutaneous_collagen | 0.26800598 |
| 102 | MP0008569_lethality_at_weaning | 0.26526729 |
| 103 | MP0009250_abnormal_appendicular_skeleto | 0.26223142 |
| 104 | MP0001614_abnormal_blood_vessel | 0.23716376 |
| 105 | MP0001784_abnormal_fluid_regulation | 0.21848552 |
| 106 | MP0005376_homeostasis/metabolism_phenot | 0.21052363 |
| 107 | MP0002066_abnormal_motor_capabilities/c | 0.20550603 |
| 108 | MP0002896_abnormal_bone_mineralization | 0.20515186 |
| 109 | MP0002734_abnormal_mechanical_nocicepti | 0.20204847 |
| 110 | MP0002822_catalepsy | 0.19623303 |
| 111 | MP0001943_abnormal_respiration | 0.19493608 |
| 112 | MP0000762_abnormal_tongue_morphology | 0.19216664 |
| 113 | MP0004924_abnormal_behavior | 0.18219516 |
| 114 | MP0005386_behavior/neurological_phenoty | 0.18219516 |
| 115 | MP0001853_heart_inflammation | 0.17526769 |
| 116 | MP0008874_decreased_physiological_sensi | 0.17238905 |
| 117 | MP0004272_abnormal_basement_membrane | 0.16904591 |
| 118 | MP0001727_abnormal_embryo_implantation | 0.16838597 |
| 119 | MP0004858_abnormal_nervous_system | 0.16188130 |
| 120 | MP0003959_abnormal_lean_body | 0.15381096 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 7.83748392 |
| 2 | Exercise-induced muscle cramps (HP:0003710) | 7.39472663 |
| 3 | Muscle hypertrophy of the lower extremities (HP:0008968) | 7.08372833 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 7.02519832 |
| 5 | Muscle fiber inclusion bodies (HP:0100299) | 6.35253689 |
| 6 | Sudden death (HP:0001699) | 6.28617064 |
| 7 | Muscle fiber splitting (HP:0003555) | 6.23404331 |
| 8 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 6.19820503 |
| 9 | Myoglobinuria (HP:0002913) | 5.68934223 |
| 10 | Hyporeflexia of lower limbs (HP:0002600) | 5.42800243 |
| 11 | Nemaline bodies (HP:0003798) | 5.35944743 |
| 12 | Abnormality of the calf musculature (HP:0001430) | 5.27515836 |
| 13 | Ventricular tachycardia (HP:0004756) | 5.06478322 |
| 14 | Type 1 muscle fiber predominance (HP:0003803) | 4.99370823 |
| 15 | Difficulty running (HP:0009046) | 4.93795915 |
| 16 | Abnormality of the left ventricular outflow tract (HP:0011103) | 4.91313436 |
| 17 | Subaortic stenosis (HP:0001682) | 4.91313436 |
| 18 | EMG: myopathic abnormalities (HP:0003458) | 4.86307666 |
| 19 | Rhabdomyolysis (HP:0003201) | 4.50297934 |
| 20 | Increased connective tissue (HP:0009025) | 4.49786031 |
| 21 | Myotonia (HP:0002486) | 4.12572921 |
| 22 | Atrial fibrillation (HP:0005110) | 4.07465283 |
| 23 | Distal arthrogryposis (HP:0005684) | 4.05129783 |
| 24 | Lipoatrophy (HP:0100578) | 4.04153505 |
| 25 | Muscle stiffness (HP:0003552) | 4.00883500 |
| 26 | Asymmetric septal hypertrophy (HP:0001670) | 3.98524014 |
| 27 | Myopathic facies (HP:0002058) | 3.82471710 |
| 28 | Primary atrial arrhythmia (HP:0001692) | 3.81234833 |
| 29 | Supraventricular tachycardia (HP:0004755) | 3.67646264 |
| 30 | Supraventricular arrhythmia (HP:0005115) | 3.59535327 |
| 31 | Round ear (HP:0100830) | 3.55149700 |
| 32 | Right ventricular cardiomyopathy (HP:0011663) | 3.48175629 |
| 33 | Difficulty climbing stairs (HP:0003551) | 3.47105946 |
| 34 | Dilated cardiomyopathy (HP:0001644) | 3.43755293 |
| 35 | Bundle branch block (HP:0011710) | 3.35851428 |
| 36 | Palpitations (HP:0001962) | 3.19934570 |
| 37 | Increased variability in muscle fiber diameter (HP:0003557) | 3.16231278 |
| 38 | Syncope (HP:0001279) | 3.15938330 |
| 39 | Abnormality of skeletal muscle fiber size (HP:0012084) | 3.15178203 |
| 40 | Ulnar deviation of the wrist (HP:0003049) | 3.13941341 |
| 41 | Rimmed vacuoles (HP:0003805) | 3.13134737 |
| 42 | Neck muscle weakness (HP:0000467) | 3.12642036 |
| 43 | Areflexia of lower limbs (HP:0002522) | 3.09289881 |
| 44 | Prolonged QT interval (HP:0001657) | 3.03402885 |
| 45 | Ventricular arrhythmia (HP:0004308) | 2.92887318 |
| 46 | Distal lower limb muscle weakness (HP:0009053) | 2.78161895 |
| 47 | Heart block (HP:0012722) | 2.77545001 |
| 48 | Abnormal atrioventricular conduction (HP:0005150) | 2.61450029 |
| 49 | Bulbar palsy (HP:0001283) | 2.55598342 |
| 50 | Atrioventricular block (HP:0001678) | 2.52258747 |
| 51 | Calcaneovalgus deformity (HP:0001848) | 2.51909391 |
| 52 | Limb-girdle muscle atrophy (HP:0003797) | 2.51082958 |
| 53 | Weak cry (HP:0001612) | 2.46334495 |
| 54 | Absent phalangeal crease (HP:0006109) | 2.46173747 |
| 55 | Muscular dystrophy (HP:0003560) | 2.43145697 |
| 56 | Ventricular fibrillation (HP:0001663) | 2.43130466 |
| 57 | Slender build (HP:0001533) | 2.41502681 |
| 58 | EMG: neuropathic changes (HP:0003445) | 2.38647734 |
| 59 | Hypoplastic ischia (HP:0003175) | 2.37433742 |
| 60 | Left ventricular hypertrophy (HP:0001712) | 2.34146752 |
| 61 | Frequent falls (HP:0002359) | 2.29419171 |
| 62 | Ketoacidosis (HP:0001993) | 2.26795335 |
| 63 | Abnormality of the calcaneus (HP:0008364) | 2.25724384 |
| 64 | Deformed tarsal bones (HP:0008119) | 2.23387371 |
| 65 | Distal lower limb amyotrophy (HP:0008944) | 2.22928946 |
| 66 | Abnormal EKG (HP:0003115) | 2.21582703 |
| 67 | Fetal akinesia sequence (HP:0001989) | 2.20886422 |
| 68 | Hyperkalemia (HP:0002153) | 2.20847332 |
| 69 | Mildly elevated creatine phosphokinase (HP:0008180) | 2.18979582 |
| 70 | Facial diplegia (HP:0001349) | 2.17075385 |
| 71 | Abnormal mitochondria in muscle tissue (HP:0008316) | 2.14931508 |
| 72 | Limb-girdle muscle weakness (HP:0003325) | 2.13822746 |
| 73 | Generalized muscle weakness (HP:0003324) | 2.13727148 |
| 74 | Proximal amyotrophy (HP:0007126) | 2.10435043 |
| 75 | Hepatic necrosis (HP:0002605) | 2.10400407 |
| 76 | Gowers sign (HP:0003391) | 2.09773598 |
| 77 | Ragged-red muscle fibers (HP:0003200) | 2.09651238 |
| 78 | Hip contracture (HP:0003273) | 2.09548449 |
| 79 | Abnormality of the ischium (HP:0003174) | 2.08336440 |
| 80 | Acute necrotizing encephalopathy (HP:0006965) | 2.08129088 |
| 81 | Testicular atrophy (HP:0000029) | 2.05012967 |
| 82 | Waddling gait (HP:0002515) | 2.02268795 |
| 83 | Scapular winging (HP:0003691) | 1.99953236 |
| 84 | Abnormality of the hip-girdle musculature (HP:0001445) | 1.99176671 |
| 85 | Abnormality of the musculature of the pelvis (HP:0001469) | 1.99176671 |
| 86 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.98556023 |
| 87 | Abnormal finger flexion creases (HP:0006143) | 1.96963873 |
| 88 | Increased muscle lipid content (HP:0009058) | 1.96719422 |
| 89 | Exercise intolerance (HP:0003546) | 1.94851794 |
| 90 | Malignant hyperthermia (HP:0002047) | 1.94481914 |
| 91 | Palmoplantar keratoderma (HP:0000982) | 1.93897228 |
| 92 | Shoulder girdle muscle weakness (HP:0003547) | 1.93605194 |
| 93 | Lower limb amyotrophy (HP:0007210) | 1.93134525 |
| 94 | Pelvic girdle muscle weakness (HP:0003749) | 1.91870434 |
| 95 | Progressive muscle weakness (HP:0003323) | 1.88907281 |
| 96 | Hepatocellular necrosis (HP:0001404) | 1.84399524 |
| 97 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 1.83927453 |
| 98 | Hypoglycemic coma (HP:0001325) | 1.81948878 |
| 99 | Acute encephalopathy (HP:0006846) | 1.81643856 |
| 100 | Large for gestational age (HP:0001520) | 1.81317824 |
| 101 | Abnormality of the foot musculature (HP:0001436) | 1.80614143 |
| 102 | Respiratory insufficiency due to muscle weakness (HP:0002747) | 1.79890914 |
| 103 | Foot dorsiflexor weakness (HP:0009027) | 1.78067851 |
| 104 | Fatigable weakness (HP:0003473) | 1.77505552 |
| 105 | Abnormality of the neuromuscular junction (HP:0003398) | 1.77505552 |
| 106 | Cholelithiasis (HP:0001081) | 1.76630632 |
| 107 | Abnormality of fatty-acid metabolism (HP:0004359) | 1.72118579 |
| 108 | Abnormality of the shoulder girdle musculature (HP:0001435) | 1.71762484 |
| 109 | Spinal rigidity (HP:0003306) | 1.71596461 |
| 110 | Ketosis (HP:0001946) | 1.70871461 |
| 111 | Increased intramyocellular lipid droplets (HP:0012240) | 1.67509362 |
| 112 | Paralysis (HP:0003470) | 1.65312686 |
| 113 | Nonprogressive disorder (HP:0003680) | 1.57656580 |
| 114 | Metatarsus adductus (HP:0001840) | 1.51331331 |
| 115 | Long clavicles (HP:0000890) | 1.44853980 |
| 116 | Ulnar deviation of finger (HP:0009465) | 1.44815958 |
| 117 | Popliteal pterygium (HP:0009756) | 1.42284600 |
| 118 | Steppage gait (HP:0003376) | 1.40045832 |
| 119 | Limited hip movement (HP:0008800) | 1.38727752 |
| 120 | Type 2 muscle fiber atrophy (HP:0003554) | 1.36026670 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | TTN | 6.68228362 |
| 2 | OBSCN | 6.33670176 |
| 3 | PHKG2 | 5.18893854 |
| 4 | PHKG1 | 5.18893854 |
| 5 | PDK3 | 2.87633774 |
| 6 | PDK4 | 2.87633774 |
| 7 | DMPK | 2.83817787 |
| 8 | NME1 | 2.72517183 |
| 9 | TRIB3 | 2.44774780 |
| 10 | MYLK | 2.29394238 |
| 11 | NEK1 | 2.28592173 |
| 12 | LMTK2 | 2.27122426 |
| 13 | BCKDK | 2.16869294 |
| 14 | PKN2 | 2.13298954 |
| 15 | PINK1 | 2.12940828 |
| 16 | PIK3CA | 2.11769804 |
| 17 | MUSK | 1.87507677 |
| 18 | MAP2K3 | 1.80436987 |
| 19 | PDK2 | 1.79213974 |
| 20 | PIK3CG | 1.76974615 |
| 21 | MAP3K7 | 1.63222998 |
| 22 | MAPK12 | 1.42327271 |
| 23 | STK24 | 1.30087256 |
| 24 | TIE1 | 1.21685145 |
| 25 | GRK7 | 1.07880655 |
| 26 | MARK1 | 1.05093510 |
| 27 | EEF2K | 1.02567851 |
| 28 | PRKAA2 | 1.02510814 |
| 29 | MAP2K4 | 1.02293505 |
| 30 | PRKAA1 | 1.00443417 |
| 31 | LIMK1 | 0.91975192 |
| 32 | TRPM7 | 0.91346993 |
| 33 | PRKD1 | 0.90180602 |
| 34 | ILK | 0.88091633 |
| 35 | CAMK2D | 0.87890831 |
| 36 | MAPKAPK3 | 0.87434085 |
| 37 | ZAK | 0.85470040 |
| 38 | PAK3 | 0.82159447 |
| 39 | MOS | 0.81653771 |
| 40 | INSRR | 0.78084641 |
| 41 | DYRK1B | 0.76419007 |
| 42 | PKN1 | 0.75128170 |
| 43 | RIPK1 | 0.74673502 |
| 44 | CCNB1 | 0.73813173 |
| 45 | TGFBR2 | 0.70306847 |
| 46 | ERBB3 | 0.67831743 |
| 47 | ROCK1 | 0.67758487 |
| 48 | MAP3K3 | 0.66166376 |
| 49 | MAP2K6 | 0.65951117 |
| 50 | NEK9 | 0.65800420 |
| 51 | EPHB1 | 0.62477061 |
| 52 | MAP3K5 | 0.61404943 |
| 53 | MAP3K13 | 0.58542491 |
| 54 | SIK1 | 0.52641214 |
| 55 | CDC42BPA | 0.48418803 |
| 56 | FLT3 | 0.47836734 |
| 57 | MAP2K1 | 0.47110371 |
| 58 | PTK6 | 0.46102180 |
| 59 | CAMK4 | 0.45680451 |
| 60 | PRKACB | 0.45346634 |
| 61 | PDGFRA | 0.45209941 |
| 62 | CAMK2G | 0.45143135 |
| 63 | WNK4 | 0.44859612 |
| 64 | CAMK2B | 0.44165650 |
| 65 | AKT2 | 0.43118806 |
| 66 | LATS2 | 0.40045125 |
| 67 | WNK1 | 0.39553340 |
| 68 | CAMK2A | 0.39012798 |
| 69 | PTK2B | 0.38592794 |
| 70 | STK38L | 0.36481821 |
| 71 | STK4 | 0.36160063 |
| 72 | ROCK2 | 0.35117226 |
| 73 | DAPK3 | 0.35026122 |
| 74 | PRKACA | 0.34281862 |
| 75 | CAMK1 | 0.33904000 |
| 76 | RPS6KC1 | 0.33215189 |
| 77 | RPS6KL1 | 0.33215189 |
| 78 | MAPK11 | 0.32337177 |
| 79 | ICK | 0.31054923 |
| 80 | PDPK1 | 0.30453170 |
| 81 | SGK2 | 0.30372116 |
| 82 | PRKACG | 0.29796910 |
| 83 | TBK1 | 0.29635683 |
| 84 | STK38 | 0.29509917 |
| 85 | SGK1 | 0.27906172 |
| 86 | MAPK7 | 0.26821038 |
| 87 | RPS6KA6 | 0.26385865 |
| 88 | PDK1 | 0.26266181 |
| 89 | CAMK1G | 0.25806011 |
| 90 | PRPF4B | 0.25761125 |
| 91 | PRKG1 | 0.25603163 |
| 92 | SGK3 | 0.24025930 |
| 93 | MAP3K4 | 0.23345856 |
| 94 | RPS6KA3 | 0.23143088 |
| 95 | MAPK10 | 0.22362932 |
| 96 | RPS6KB1 | 0.22327053 |
| 97 | RPS6KA1 | 0.22018851 |
| 98 | PRKCH | 0.20950821 |
| 99 | MAP3K1 | 0.19609136 |
| 100 | ARAF | 0.18210912 |
| 101 | MAP3K11 | 0.17805450 |
| 102 | MAP3K6 | 0.17424682 |
| 103 | MAPK13 | 0.17230643 |
| 104 | MARK2 | 0.16997506 |
| 105 | TAOK1 | 0.16930842 |
| 106 | MTOR | 0.16705826 |
| 107 | RET | 0.16483470 |
| 108 | KDR | 0.16156959 |
| 109 | TYK2 | 0.16061331 |
| 110 | RPS6KB2 | 0.14895596 |
| 111 | PRKD3 | 0.14362227 |
| 112 | MARK3 | 0.13766030 |
| 113 | TAOK2 | 0.13738078 |
| 114 | PRKCE | 0.13532247 |
| 115 | JAK1 | 0.13497696 |
| 116 | ZAP70 | 0.12998623 |
| 117 | PAK6 | 0.12938618 |
| 118 | RPS6KA2 | 0.12936815 |
| 119 | SGK223 | 0.12574258 |
| 120 | SGK494 | 0.12574258 |
| 121 | DAPK2 | 0.12436299 |
| 122 | JAK2 | 0.11304976 |
| 123 | STK11 | 0.10905287 |
| 124 | MAPK4 | 0.09915750 |
| 125 | FER | 0.09282499 |
| 126 | KSR2 | 0.07534034 |
| 127 | RAF1 | 0.07317664 |
| 128 | LATS1 | 0.06151913 |
| 129 | CDK19 | 0.04390293 |
| 130 | MAPK9 | 0.04209364 |
| 131 | MAP3K10 | 0.03724321 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 5.50529030 |
| 2 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 4.18124317 |
| 3 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 4.11425121 |
| 4 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 3.97631415 |
| 5 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 3.79269565 |
| 6 | Propanoate metabolism_Homo sapiens_hsa00640 | 3.07038630 |
| 7 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 3.06352106 |
| 8 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 2.90026237 |
| 9 | Parkinsons disease_Homo sapiens_hsa05012 | 2.66475955 |
| 10 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 2.52741097 |
| 11 | Fatty acid degradation_Homo sapiens_hsa00071 | 2.45249342 |
| 12 | Carbon metabolism_Homo sapiens_hsa01200 | 2.36284408 |
| 13 | Alzheimers disease_Homo sapiens_hsa05010 | 2.09687711 |
| 14 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 2.05995495 |
| 15 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 1.96227640 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.85715240 |
| 17 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.85518408 |
| 18 | Viral myocarditis_Homo sapiens_hsa05416 | 1.73447282 |
| 19 | Pyruvate metabolism_Homo sapiens_hsa00620 | 1.72892223 |
| 20 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 1.65285809 |
| 21 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 1.52859325 |
| 22 | Huntingtons disease_Homo sapiens_hsa05016 | 1.50023777 |
| 23 | Insulin resistance_Homo sapiens_hsa04931 | 1.46658459 |
| 24 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 1.42751671 |
| 25 | Insulin signaling pathway_Homo sapiens_hsa04910 | 1.39413580 |
| 26 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 1.33987142 |
| 27 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 1.31469293 |
| 28 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.22928744 |
| 29 | Biosynthesis of amino acids_Homo sapiens_hsa01230 | 1.18430317 |
| 30 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.12079601 |
| 31 | Circadian rhythm_Homo sapiens_hsa04710 | 1.11649835 |
| 32 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.11335920 |
| 33 | AMPK signaling pathway_Homo sapiens_hsa04152 | 1.08471763 |
| 34 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.06946573 |
| 35 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.96601623 |
| 36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.94892375 |
| 37 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 0.90818073 |
| 38 | Galactose metabolism_Homo sapiens_hsa00052 | 0.89680107 |
| 39 | Fatty acid elongation_Homo sapiens_hsa00062 | 0.86770809 |
| 40 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 0.84300333 |
| 41 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.81368549 |
| 42 | Arginine biosynthesis_Homo sapiens_hsa00220 | 0.81111367 |
| 43 | Focal adhesion_Homo sapiens_hsa04510 | 0.78232463 |
| 44 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.77934388 |
| 45 | Long-term potentiation_Homo sapiens_hsa04720 | 0.77648883 |
| 46 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.77535090 |
| 47 | Glycine, serine and threonine metabolism_Homo sapiens_hsa00260 | 0.74873771 |
| 48 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.73152050 |
| 49 | Tight junction_Homo sapiens_hsa04530 | 0.70826795 |
| 50 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.69950734 |
| 51 | Gastric acid secretion_Homo sapiens_hsa04971 | 0.69142389 |
| 52 | Tryptophan metabolism_Homo sapiens_hsa00380 | 0.63005793 |
| 53 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.60877657 |
| 54 | Longevity regulating pathway - mammal_Homo sapiens_hsa04211 | 0.60328780 |
| 55 | Renin secretion_Homo sapiens_hsa04924 | 0.60003996 |
| 56 | Lysine degradation_Homo sapiens_hsa00310 | 0.57079154 |
| 57 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.57030338 |
| 58 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.56818533 |
| 59 | Insulin secretion_Homo sapiens_hsa04911 | 0.56629885 |
| 60 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 0.50953857 |
| 61 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 0.47290245 |
| 62 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.46570366 |
| 63 | Phenylalanine metabolism_Homo sapiens_hsa00360 | 0.43247482 |
| 64 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 0.43099202 |
| 65 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.42018186 |
| 66 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 0.41276353 |
| 67 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.38489267 |
| 68 | Peroxisome_Homo sapiens_hsa04146 | 0.38132485 |
| 69 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.37216399 |
| 70 | mTOR signaling pathway_Homo sapiens_hsa04150 | 0.36704133 |
| 71 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.35166904 |
| 72 | cAMP signaling pathway_Homo sapiens_hsa04024 | 0.35025514 |
| 73 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 0.33765552 |
| 74 | Amoebiasis_Homo sapiens_hsa05146 | 0.33247547 |
| 75 | Adherens junction_Homo sapiens_hsa04520 | 0.32687619 |
| 76 | Circadian entrainment_Homo sapiens_hsa04713 | 0.31097685 |
| 77 | Amphetamine addiction_Homo sapiens_hsa05031 | 0.29117786 |
| 78 | Platelet activation_Homo sapiens_hsa04611 | 0.28691338 |
| 79 | VEGF signaling pathway_Homo sapiens_hsa04370 | 0.28340998 |
| 80 | Histidine metabolism_Homo sapiens_hsa00340 | 0.26572195 |
| 81 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.25791047 |
| 82 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.25256428 |
| 83 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 0.25081480 |
| 84 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.24439333 |
| 85 | Long-term depression_Homo sapiens_hsa04730 | 0.24298558 |
| 86 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.23883732 |
| 87 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.23755041 |
| 88 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.21767667 |
| 89 | Melanogenesis_Homo sapiens_hsa04916 | 0.20514784 |
| 90 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 0.20324703 |
| 91 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 0.18411013 |
| 92 | Cholinergic synapse_Homo sapiens_hsa04725 | 0.17923031 |
| 93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.15614453 |
| 94 | Purine metabolism_Homo sapiens_hsa00230 | 0.15512349 |
| 95 | Metabolic pathways_Homo sapiens_hsa01100 | 0.15338498 |
| 96 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.15271322 |
| 97 | Glioma_Homo sapiens_hsa05214 | 0.14237159 |
| 98 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 0.12593832 |
| 99 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.11789153 |
| 100 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.11757074 |
| 101 | Sulfur relay system_Homo sapiens_hsa04122 | 0.11186023 |
| 102 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.09386757 |
| 103 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.09327816 |
| 104 | Fat digestion and absorption_Homo sapiens_hsa04975 | 0.09040733 |
| 105 | Gap junction_Homo sapiens_hsa04540 | 0.08789027 |
| 106 | Bile secretion_Homo sapiens_hsa04976 | 0.08607177 |
| 107 | Amyotrophic lateral sclerosis (ALS)_Homo sapiens_hsa05014 | 0.08389771 |
| 108 | Oocyte meiosis_Homo sapiens_hsa04114 | 0.08097126 |
| 109 | Tyrosine metabolism_Homo sapiens_hsa00350 | 0.08009257 |
| 110 | Salivary secretion_Homo sapiens_hsa04970 | 0.06842799 |
| 111 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.05601125 |
| 112 | Toxoplasmosis_Homo sapiens_hsa05145 | 0.03709042 |
| 113 | Olfactory transduction_Homo sapiens_hsa04740 | 0.03636147 |
| 114 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.03336271 |
| 115 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.02643555 |
| 116 | ABC transporters_Homo sapiens_hsa02010 | 0.02058996 |

